Epidemiological review highlights rising rates of diabetic nephropathy in diabetic populations, underscoring an urgent need to prevent podocyte damage.
Diabetic nephropathy (DN) is one of the most common chronic serious complications of diabetes mellitus (DM) and the leading cause of end-stage renal disease. The prevalence of DM has been increasing worldwide. It is estimated that the people with diabetes worldwide will increase from 382 million in 2013 to 592 million by 2035, according to the International Diabetes Federation
No takes yet. Share an insight, caveat, or question.
Dai et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: